Trends in Clostridioides difficile infection prevalence among pediatric cancer patients: A systematic review and meta-analysis
Trends in Clostridioides-difficile-Infektionsprävalenz bei pädiatrischen Krebspatient:innen: systematische Übersicht und Metaanalyse
PLOS One · 15.10.2025 · 20 (10) · e0333962
DOI: 10.1371/journal.pone.0333962 ↗Auf einen Blick
Die Metaanalyse zeigt bei pädiatrischen Krebspatient:innen eine gepoolte CDI-Prävalenz von 15,41 % (95 %-KI 10,57–20,24 %).
Fragestellung
Wie hoch ist die globale gepoolte Prävalenz von Clostridioides-difficile-Infektionen bei pädiatrischen Krebspatient:innen?
Methode
Systematische Übersicht und Metaanalyse nach PRISMA; 20 Artikel von 1985 bis 2024; Random-Effects-Modell, Heterogenitäts-, Subgruppen-, Sensitivitäts- und Meta-Regression-Analysen.
Ergebnisse
15,41 % (95 %-KI 10,57–20,24 %); hohe Heterogenität (I 2 = 99,90 %; p < 0,001). Asia: 23,23 % (95 %-KI 17,44–29,01 %); prospektive Studien: 20,64 % (95 %-KI 14,25–27,03 %).
Einschränkungen
Hohe Heterogenität; Quellen der Heterogenität nur teilweise geklärt.
Schlussfolgerung der Autor:innen
Es besteht eine erhebliche CDI-Belastung bei pädiatrischen Krebspatient:innen. Die Befunde unterstreichen die Notwendigkeit regelmäßiger Erkennung und gezielter Behandlung.
Kernaussagen
- Gepoolte CDI-Prävalenz: 15,41 %
- Hohe Heterogenität: I 2 = 99,90 %
- Höhere Prävalenz in Asien und in prospektiven Studien
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS One, online erschienen am 15.10.2025. Verfasst von Muluneh Assefa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gond…. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Pediatric cancer patients are highly susceptible to Clostridioides difficile infection (CDI) due to immunosuppression, prolonged hospitalization, and antibiotic exposure. This study determined the global pooled prevalence of CDI among pediatric cancer patients.
Methods
According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, 20 available articles published between 1985 and 2024 were included in this study. The extracted data from the relevant articles were analyzed using STATA version 17.0. The effect size estimate was computed using a random-effects model, considering a 95% confidence interval. The I 2 statistic and Galbraith plot were used to confirm heterogeneity. Univariate meta-regression, sensitivity, and subgroup analyses were conducted to identify the source of heterogeneity. Egger’s test and a funnel plot were used to check for publication bias.
Results
The pooled prevalence of CDI was 15.41% (95% CI: 10.57–20.24%), with high heterogeneity (I 2 = 99.90%) and statistical significance (p < 0.001). The trend in the study year was a minimum prevalence of 0.96% in 2016–2020 (Brazil) and a maximum prevalence of 38.26% in 2007–2017 (USA). In the subgroup analysis, a relatively high prevalence of CDI was observed in Asia (23.23%; 95% CI: 17.44–29.01%) and prospective studies (20.64%; 95% CI: 14.25–27.03%), and studies included pediatric patients with hematologic, solid tumors, and hematopoietic stem cell transplantation recipients (18.34%; 95% CI: 8.05–28.63%). The test of group differences (p < 0.001) in the continent in subgroup analysis and sample size (p = 0.049) in univariate meta-regression were sources of heterogeneity between the effect sizes of the individual studies.
Conclusion
There is a significant burden of CDI in pediatric cancer patients. These findings highlight the need for regular detection and targeted treatment of CDI, including drug-resistant strains, in cancer patients to minimize severe complications and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
- Department of Medical and Surgical Nursing, Faculty of Nursing, University of Tabuk, Tabuk, Saudi Arabia.
- Department of Immunology and Molecular Biology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
ORCID-Profile: Muluneh Assefa, Getu Girmay, Mitkie Tigabie
Zitieren
APA
Assefa, M., Biset, S., Amare, A., Almagharbeh, W. T., Girmay, G., & Tigabie, M. (2025). Trends in Clostridioides difficile infection prevalence among pediatric cancer patients: A systematic review and meta-analysis. PLOS One, 20(10), e0333962. https://doi.org/10.1371/journal.pone.0333962
Vancouver
Assefa M, Biset S, Amare A, Almagharbeh WT, Girmay G, Tigabie M. Trends in Clostridioides difficile infection prevalence among pediatric cancer patients: A systematic review and meta-analysis. PLOS One. 2025;20(10):e0333962. doi:10.1371/journal.pone.0333962
BibTeX
@article{Assefa2025,
author = {Assefa, Muluneh and Biset, Sirak and Amare, Azanaw and Almagharbeh, Wesam Taher and Girmay, Getu and Tigabie, Mitkie},
title = {Trends in Clostridioides difficile infection prevalence among pediatric cancer patients: A systematic review and meta-analysis},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {10},
pages = {e0333962},
doi = {10.1371/journal.pone.0333962}
}
EUVIMED